CovarsaDx Strengthens Regulatory Expertise with Industry Veteran David Ikeda

LOS ANGELES, Feb. 10, 2025 /PRNewswire/ — CovarsaDx, a prominent Clinical Research Organization (CRO) well-known for its expertise in the areas of in vitro diagnostics (IVDs) and medical devices, proudly announces the addition of David Ikeda as senior regulatory affairs strategist. Ikeda…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks